Vimarsana
Biggest News Aggregation in the World

Page 3 - Director Eric News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Eric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Eric Today - Breaking & Trending Today

6,088 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Summit Global Investments - Vimarsana News

6,088 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Summit Global Investments

Summit Global Investments purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other institutional investors have also recently made changes to […]

Source: wkrb13.com
Summit Global Investments Makes New $1.58 Million Investment in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Summit Global Investments Makes New $1.58 Million Investment in Biogen Inc. (NASDAQ:BIIB)

Summit Global Investments bought a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other large investors also recently bought and sold shares of BIIB. International Assets […]

Biogen's (BIIB) Outperform Rating Reiterated at Oppenheimer - Vimarsana News

Biogen's (BIIB) Outperform Rating Reiterated at Oppenheimer

Oppenheimer reissued their outperform rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $270.00 target price on the biotechnology company’s stock. Several other research analysts have also recently weighed in on the stock. Truist Financial reiterated a buy rating […]

Biogen Inc. (NASDAQ:BIIB) Receives $295.58 Average PT from Analysts - Vimarsana News

Biogen Inc. (NASDAQ:BIIB) Receives $295.58 Average PT from Analysts

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-seven brokerages that are currently covering the firm, MarketBeat reports. Nine research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. The average 1 year price objective […]

Investment House LLC Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Investment House LLC Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

Investment House LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in Biogen were worth $846,000 as of its most recent SEC filing. […]